Sautter, J <br/><br/>
Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatum.  [electronic resource] 

 -  Experimental neurology  Jul 2000 
 - 121-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-4886 
<br/><br/><label>Standard No.: </label>10.1006/exnr.2000.7410  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Brain Tissue Transplantation<br/>Cell Count--drug effects<br/>Cell Survival--drug effects<br/>Corpus Striatum--cytology<br/>Cryopreservation--methods<br/>Disease Models, Animal<br/>Female<br/>Fetal Tissue Transplantation<br/>G(M1) Ganglioside--pharmacology<br/>Graft Survival--drug effects<br/>Mesencephalon--cytology<br/>Motor Activity--drug effects<br/>Neurons--cytology<br/>Neuroprotective Agents--pharmacology<br/>Oxidopamine<br/>Parkinson Disease, Secondary--chemically induced<br/>Pregnatrienes--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Recovery of Function--drug effects<br/>Tyrosine 3-Monooxygenase--metabolism